Marketing-authorisation holder · United States
Novitium Pharma
22 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
22 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CARGLUMIC ACID200mg · Tablet, for suspension | Carglumic acid | United States | Marketed | 2021 |
| ESTRADIOL0.5mg | 1mg | 2mg · Tablet | Estradiol | United States | Marketed | 1996 |
| FELBAMATE600mg/5ml · Suspension | Felbamate | United States | Marketed | 2011 |
| FLURAZEPAM HYDROCHLORIDE15mg | 30mg · Capsule | Flurazepam | United States | Marketed | 1985 |
| INDOMETHACIN25mg/5ml · Suspension | Indometacin | United States | Marketed | 1987 |
| INZIRQO10mg/ml · For suspension | Hydrochlorothiazide | United States | Marketed | 2025 |
| LEVOCARNITINE330mg · Tablet | Levocarnitine | United States | Marketed | 2004 |
| LEVOCARNITINE SF1gm/10ml · Solution | Levocarnitine | United States | Marketed | 2019 |
| LEVOFLOXACIN250mg/10ml · Solution | Levofloxacin | United States | Marketed | 2011 |
| METHSUXIMIDE300mg · Capsule | Mesuximide | United States | Marketed | 2023 |
| METHYLTESTOSTERONE10mg · Capsule | Methyltestosterone | United States | Marketed | 2015 |
| NAPROXEN375mg | 500mg · Tablet, delayed release | Naproxen | United States | Marketed | 1998 |
| NAPROXEN25mg/ml · Suspension | Naproxen | United States | Marketed | 1994 |
| OMEPRAZOLE AND SODIUM BICARBONATE20mg/packet; 1.68gm/packet | 40mg/packet; 1.68gm/packet · For suspension | Omeprazole, Bicarbonate | United States | Marketed | 2013 |
| PAROXETINE HYDROCHLORIDE10mg base/5ml · Suspension | Paroxetine | United States | Marketed | 2006 |
| PYRIDOSTIGMINE BROMIDE60mg/5ml · Syrup | Pyridostigmine | United States | Marketed | 2019 |
| RANITIDINE HYDROCHLORIDE150mg base | 300mg base · Capsule | Ranitidine | United States | Marketed | 1997 |
| SOVUNA200mg | 300mg · Tablet | Hydroxychloroquine | United States | Marketed | 2022 |
| TEZRULY1mg base/ml · Solution | Terazosin | United States | Not marketed | 2024 |
| THIOTHIXENE10mg | 1mg | 20mg | 2mg | 5mg · Capsule | Tiotixene | United States | Marketed | 1987 |
| VALSARTAN4mg/ml · Solution | Valsartan | United States | Marketed | 2021 |
| PITOLISANT17.8mg · Tablet | Pitolisant | United States | tentative | 2025 |